Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons | Zendy

Michael Donohue | Zendy; Reisa A. Sperling | Zendy; Ronald C. Petersen | Zendy; ChungKai Sun | Zendy; Michael W. Weiner | Zendy; Paul Aisen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

Author(s) -

Michael Donohue,

Reisa A. Sperling,

Ronald C. Petersen,

ChungKai Sun,

Michael W. Weiner,

Paul Aisen

Publication year - 2017

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2017.6669

Subject(s) - medicine , dementia , interquartile range , positron emission tomography , cognitive decline , clinical dementia rating , alzheimer's disease neuroimaging initiative , neuroimaging , cognition , standardized uptake value , amyloid (mycology) , pittsburgh compound b , biomarker , alzheimer's disease , disease , psychiatry , pathology , nuclear medicine , biochemistry , chemistry

Among cognitively normal individuals, elevated brain amyloid (defined by cerebrospinal fluid assays or positron emission tomography regional summaries) can be related to risk for later Alzheimer-related cognitive decline.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research